Your browser doesn't support javascript.
loading
Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy.
Chen, Wei; Li, Dapeng; Bian, Xuyu; Wu, Yan; Xu, Mengdan; Wu, Mengyao; Tao, Min.
Afiliación
  • Chen W; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li D; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Bian X; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wu Y; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xu M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wu M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Tao M; Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Nutr Cancer ; 75(1): 207-218, 2023.
Article en En | MEDLINE | ID: mdl-36190755
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nutr Cancer Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nutr Cancer Año: 2023 Tipo del documento: Article